header logo image


Page 22«..10..21222324..3040..»

Axonis Therapeutics raises $115 million in Series A financing – The Pharma Letter

November 3rd, 2024 2:43 am

Axonis Therapeutics raises $115 million in Series A financing  The Pharma Letter

Read this article:
Axonis Therapeutics raises $115 million in Series A financing - The Pharma Letter

Read More...

Regeneron third-quarter 2024 earnings top expectations – The Pharma Letter

November 3rd, 2024 2:43 am

Regeneron third-quarter 2024 earnings top expectations  The Pharma Letter

Here is the original post:
Regeneron third-quarter 2024 earnings top expectations - The Pharma Letter

Read More...

AbbVie inks up to $1.4 billion deal with EvolveImmune – The Pharma Letter

November 3rd, 2024 2:43 am

AbbVie inks up to $1.4 billion deal with EvolveImmune  The Pharma Letter

See the original post:
AbbVie inks up to $1.4 billion deal with EvolveImmune - The Pharma Letter

Read More...

CEO and Chairman of the Executive Board – European Biotechnology News

November 3rd, 2024 2:43 am

CEO and Chairman of the Executive Board  European Biotechnology News

See more here:
CEO and Chairman of the Executive Board - European Biotechnology News

Read More...

The transformative potential of biotechnology and AI in healthcare – The Armchair Trader

November 3rd, 2024 2:43 am

The transformative potential of biotechnology and AI in healthcare  The Armchair Trader

Read more from the original source:
The transformative potential of biotechnology and AI in healthcare - The Armchair Trader

Read More...

A Year of DMD Gene Therapy Trial Failures – AJMC.com Managed Markets Network

November 3rd, 2024 2:42 am

A Year of DMD Gene Therapy Trial Failures  AJMC.com Managed Markets Network

More:
A Year of DMD Gene Therapy Trial Failures - AJMC.com Managed Markets Network

Read More...

Hemophilia B: Gene Therapy Shows Promise – Medscape

November 3rd, 2024 2:42 am

Hemophilia B: Gene Therapy Shows Promise  Medscape

Excerpt from:
Hemophilia B: Gene Therapy Shows Promise - Medscape

Read More...

Around the Helix: Cell and Gene Therapy Company Updates October 30, 2024 – CGTLive

November 3rd, 2024 2:42 am

Around the Helix: Cell and Gene Therapy Company Updates October 30, 2024  CGTLive

See more here:
Around the Helix: Cell and Gene Therapy Company Updates October 30, 2024 - CGTLive

Read More...

2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers – PharmaVoice

November 3rd, 2024 2:42 am

2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers  PharmaVoice

Go here to read the rest:
2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers - PharmaVoice

Read More...

Cell therapy weekly: support for commercialization of complex therapies – RegMedNet

November 3rd, 2024 2:42 am

Cell therapy weekly: support for commercialization of complex therapies  RegMedNet

Read more from the original source:
Cell therapy weekly: support for commercialization of complex therapies - RegMedNet

Read More...

Lexeo shares early data on Alzheimers gene therapy – Endpoints News

November 3rd, 2024 2:42 am

Lexeo shares early data on Alzheimers gene therapy  Endpoints News

Excerpt from:
Lexeo shares early data on Alzheimers gene therapy - Endpoints News

Read More...

Medicaid Aiming to Improve Patient Access to High-Cost Therapies – AJMC.com Managed Markets Network

November 3rd, 2024 2:42 am

Medicaid Aiming to Improve Patient Access to High-Cost Therapies  AJMC.com Managed Markets Network

Link:
Medicaid Aiming to Improve Patient Access to High-Cost Therapies - AJMC.com Managed Markets Network

Read More...

The Significance of Gene Therapy in Neuromuscular Medicine at the 2025 MDA Conference: Paul Melmeyer, MPP – Neurology Live

November 3rd, 2024 2:42 am

The Significance of Gene Therapy in Neuromuscular Medicine at the 2025 MDA Conference: Paul Melmeyer, MPP  Neurology Live

View original post here:
The Significance of Gene Therapy in Neuromuscular Medicine at the 2025 MDA Conference: Paul Melmeyer, MPP - Neurology Live

Read More...

OHSU researchers identify gene that could be key to future HIV vaccine – OHSU News

November 3rd, 2024 2:42 am

OHSU researchers identify gene that could be key to future HIV vaccine  OHSU News

Excerpt from:
OHSU researchers identify gene that could be key to future HIV vaccine - OHSU News

Read More...

Purespring gene therapy reduces kidney scarring in mice and is stably expressed in pigs – Fierce Biotech

November 3rd, 2024 2:42 am

Purespring gene therapy reduces kidney scarring in mice and is stably expressed in pigs  Fierce Biotech

Visit link:
Purespring gene therapy reduces kidney scarring in mice and is stably expressed in pigs - Fierce Biotech

Read More...

Data Roundup: October 2024 Features Update for TCR-Based Autologous Cell Therapy in Melanoma, the First Clinical Demonstration of Therapeutic RNA…

November 3rd, 2024 2:42 am

Data Roundup: October 2024 Features Update for TCR-Based Autologous Cell Therapy in Melanoma, the First Clinical Demonstration of Therapeutic RNA Editing in Humans, and More  CGTLive

Read more from the original source:
Data Roundup: October 2024 Features Update for TCR-Based Autologous Cell Therapy in Melanoma, the First Clinical Demonstration of Therapeutic RNA...

Read More...

NewBiologix Launches Xcell to Accelerate, Optimize, and Scale Gene and Cell Therapy Production – Business Wire

November 3rd, 2024 2:42 am

NewBiologix Launches Xcell to Accelerate, Optimize, and Scale Gene and Cell Therapy Production  Business Wire

Go here to read the rest:
NewBiologix Launches Xcell to Accelerate, Optimize, and Scale Gene and Cell Therapy Production - Business Wire

Read More...

Vertex Pharmaceuticals and CRISPR Therapeutics Casgevy: the 200 Best Inventions of 2024 – TIME

November 3rd, 2024 2:42 am

Vertex Pharmaceuticals and CRISPR Therapeutics Casgevy: the 200 Best Inventions of 2024  TIME

Read this article:
Vertex Pharmaceuticals and CRISPR Therapeutics Casgevy: the 200 Best Inventions of 2024 - TIME

Read More...

Addressing gene and cell therapy commercialization challenges – TechTarget

November 3rd, 2024 2:42 am

Addressing gene and cell therapy commercialization challenges  TechTarget

Link:
Addressing gene and cell therapy commercialization challenges - TechTarget

Read More...

University of Pennsylvania gene therapy spinout Interius BioTherapeutics doses patient, achieves CAR therapy first – The Business Journals

November 3rd, 2024 2:42 am

University of Pennsylvania gene therapy spinout Interius BioTherapeutics doses patient, achieves CAR therapy first  The Business Journals

More here:
University of Pennsylvania gene therapy spinout Interius BioTherapeutics doses patient, achieves CAR therapy first - The Business Journals

Read More...

Page 22«..10..21222324..3040..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick